Neovasc Inc. 3Y Shareholders Equity Growth (per Share)

3Y Shareholders Equity Growth (per Share) of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including 3Y Shareholders Equity Growth (per Share) growth rates and interactive chart.


Highlights and Quick Summary

  • Annual 3Y Shareholders Equity Growth (per Share) for 2021 was 0.0% (a NaN% decrease from previous year)
  • Annual 3Y Shareholders Equity Growth (per Share) for 2020 was 0.0% (a NaN% decrease from previous year)
  • Annual 3Y Shareholders Equity Growth (per Share) for 2019 was 0.0% (a NaN% decrease from previous year)
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical 3Y Shareholders Equity Growth (per Share) of Neovasc Inc.

Most recent 3Y Shareholders Equity Growth (per Share)of NVCN including historical data for past 10 years.

Interactive Chart of 3Y Shareholders Equity Growth (per Share) of Neovasc Inc.

Neovasc Inc. 3Y Shareholders Equity Growth (per Share) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 0.0%
2020 0.0%
2019 0.0%
2018 0.0%
2017 0.0%
2016 0.0%
2015 0.0%
2014 0.0%
2013 0.0%
2012 -42.96%
2011 -28.3%

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.